Attached files
| file | filename |
|---|---|
| EX-16.1 - Tanke Biosciences Corp | e609255_ex16-1.htm |
|
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
______________________
|
|
FORM 8-K/A
|
|
CURRENT REPORT
|
|
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
|
|
Date of Report (Date of earliest event reported)
|
January 20, 2012
|
|
Tanke Biosciences Corporation
|
|
(Exact name of registrant as specified in its charter)
|
|
Nevada
|
000-53529
|
26-3853855
|
||
|
(State or other jurisdiction
of incorporation)
|
(Commission
File Number)
|
(I.R.S. Employer
Identification No.)
|
|
Room 2801, East Tower of Hui Hao Building, No. 519 Machang Road, Pearl River New City, Guangzhou, People’s Republic of China
|
510627
|
|
|
(Address of principal executive offices)
|
(Zip Code)
|
|
Registrant’s telephone number, including area code +86-20-38859025
|
|
N/A
|
|
(Former name or former address, if changed since last report.)
|
|
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
|
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
¨¨¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
¨¨¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
¨¨¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13a-4(c))
|
EXPLANATORY NOTE
This Amendment No. 1 (this “Amendment”) to the Current Report on Form 8-K of Tanke Biosciences Corp. (the “Company”) as filed with the Securities and Exchange Commission (“SEC”) on January 26, 2012 (the “Original 8-K”) is being filed to include as Exhibit 16.1 the letter from Parker Randall CF (H.K.) CPA Limited, dated January 31, 2012.
|
Item 4.01
|
Changes in Registrant’s Certifying Accountant.
|
Dismissal of Previous Independent Registered Public Accounting Firm
On January 20, 2012, our Board of Directors approved the dismissal of Parker Randall CF (HK) CPA Limited (“Parker Randall”) as our independent auditor, effective immediately.
Parker Randall’s reports on our financial statements as of and for the fiscal years ended December 31, 2010 and 2009 did not contain an adverse opinion or disclaimer of opinion and were not qualified or modified as to uncertainty, audit scope, or accounting principles.
During the fiscal years ended December 31, 2010 and 2009 and through Parker Randall’s dismissal on January 20, 2012, there were (1) no disagreements with Parker Randall on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedures, which disagreements, if not resolved to the satisfaction of Parker Randall, would have caused Parker Randall to make reference to the subject matter of the disagreements in connection with its reports, and (2) no events of the type listed in paragraphs (A) through (D) of Item 304(a)(1)(v) of Regulation S-K.
We furnished Parker Randall with a copy of this disclosure on January 20, 2012, providing Parker Randall with the opportunity to furnish the Company with a letter addressed to the SEC stating whether it agrees with the statements made by us herein in response to Item 304(a) of Regulation S-K and, if not, stating the respect in which it does not agree. A copy of Parker Randall’s letter to the SEC is filed as Exhibit 16.1 to this Report.
Engagement of New Independent Registered Public Accounting Firm
Concurrent with the decision to dismiss Parker Randall as our independent auditor, the Board of Directors appointed EFP Rotenberg LLP (“EFP”) as our independent auditor.
During the years ended December 31, 2010 and 2009 and through the date hereof, neither the Company nor anyone acting on its behalf consulted EFP with respect to (i) the application of accounting principles to a specified transaction, either completed or proposed, or the type of audit opinion that might be rendered on the Company’s financial statements, and neither a written report was provided to the Company or oral advice was provided that EFP concluded was an important factor considered by the Company in reaching a decision as to the accounting, auditing or financial reporting issue; or (ii) any matter that was the subject of a disagreement or reportable events set forth in Item 304(a)(1)(iv) and (v), respectively, of Regulation S-K.
|
Item 8.01
|
Other Events.
|
On January 26, 2012, we issued a press release announcing the change of auditor. A copy of the press release is furnished as Exhibit 99.1 to this Form 8-K.
|
Item 9.01
|
Financial Statements and Exhibits.
|
(d) Exhibits.
|
Exhibit No.
|
Description
|
|
|
16.1
|
Letter from Parker Randall CF (H.K.) CPA Limited, dated January 31, 2011
|
|
|
99.1
|
Press Release [Incorporated by reference to the Company’s Current Report on Form 8-K filed with the SEC on January 26, 2012]
|
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
Date: January 31, 2012
|
TANKE BIOSCIENCES CORPORATION
|
|||
|
By:
|
/s/ Guixiong Qiu
|
|||
|
Name:
|
Guixiong Qiu
|
|||
|
Title:
|
Chief Executive Officer
|
|||